Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. Journal of Carcinogenesis, [S. l.], v. 10, n. 1, 2011. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/146. Acesso em: 12 mar. 2026.